Compound Q&A

What is the market or research trend for Pituitary adenylate cyclase-activating peptide (CAS: 137061-48-4)?

Answer

Pituitary adenylate cyclase-activating peptide
The market for Pituitary adenylate cyclase-activating peptide (PACAP, CAS: 137061-48-4) is growing due to its potential in neuroprotection and neurotrophic effects. Research trends are focusing on its application in neurodegenerative diseases and pain management. Market analysis indicates increasing demand for this peptide in pharmaceutical and academic research, driven by positive clinical trials and emerging applications.

About

English Name Pituitary adenylate cyclase-activating peptide
Molecular Formula C203H331N63O53S1
Molecular Weight 4534.26 g/mol
SMILES [H]/N=C(/NCCC[C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N)CCCCN)=O)CC(=O)N)=O)CCCCN)=O)C(C)C)=O)CCCN/C(=N/[H])/N)=O)CCC(=O)N)=O)CCCCN)=O)CC1=CC=C(O)C=C1)=O)NC([C@@H](NC(CNC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](C(C)C)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]([C@H](O)C)NC([C@@H](NC([C@H]([C@H](CC)C)NC(CNC([C@@H](NC([C@@H](NC([C@H](CC1N=CNC=1)N)=O)CO)=O)CC(=O)O)=O)=O)=O)CC1=CC=CC=C1)=O)=O)CC(=O)O)=O)CO)=O)CC1=CC=C(O)C=C1)=O)CO)=O)CCCN/C(=N/[H])/N)=O)CC1=CC=C(O)C=C1)=O)CCCN/C(=N/[H])/N)=O)CCCCN)=O)CCC(=O)N)=O)CCSC)=O)C)=O)=O)CCCCN)=O)CCCCN)=O)CC1=CC=C(O)C=C1)=O)CC(C)C)=O)C)=O)C)=O)=O)CC(C)C)=O)=O)CCCCN)=O)\N
InChIKey UFTCZKMBJOPXDM-XXFCQBPRSA-N
Last Updated: 2025-10-23 12:19

Related Q&A

Compound Q&A

What regulatory guidelines apply to Pituitary adenylate cyclase-activating peptide (CAS: 137061-48-4)?

Pituitary adenylate cyclase-activating peptide (PACAP, CAS: 137061-48-4) is subject to various regul...

Compound Q&A

Are there alternatives to Pituitary adenylate cyclase-activating peptide (CAS: 137061-48-4) in synthesis?

For synthesis, alternatives to Pituitary adenylate cyclase-activating peptide (PACAP, CAS: 137061-48...

Compound Q&A

How should waste containing Pituitary adenylate cyclase-activating peptide (CAS: 137061-48-4) be handled?

Waste containing Pituitary adenylate cyclase-activating peptide (PACAP, CAS: 137061-48-4) should be ...

Compound Q&A

How should waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3) be handled?

Waste containing N-Methoxy-N-methyl-1,3-thiazole-5-carboxamide (CAS: 898825-89-3...

898825-89-3N-Methoxy-N-methyl-1...
Compound Q&A

How should N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine (CAS: 1318338-47-4) be stored?

N-(4-Biphenylyl)dibenzo[b,d]furan-4-amine should be stored in a tightly sealed c...

1318338-47-4N-(4-Biphenylyl)dibe...
Compound Q&A

What is the market or research trend for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1)?

The market for 3-Acetamido-5-amino-2,4,6-triiodobenzoic acid (CAS: 1713-07-1) is...

1713-07-13-Acetamido-5-amino-...
Compound Q&A

How should Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) be stored?

Benzyl 2-O-acetyl-3,4,6-tri-O-benzyl-beta-D-galactopyranoside (CAS: 61820-03-9) ...

61820-03-9Benzyl 2-O-acetyl-3,...